Timothy E. Davis, Jr.

Timothy (Ted) E. Davis, Jr. has served as a member of the board of directors since the inception in April 2008. Mr. Davis joined BioTissue,Inc., a market leader in regenerative therapies for treating the ocular surface and other surgical indications, as President and Chief Executive Officer in January 2022. He previously served as President and Chief Executive Officer of Active Implants, LLC, a company focused on the knee preservation segment of sports medicine from 2017 through 2021. From January 2014 through September 2015, Mr. Davis served as Chief Executive Officer of MicroPort Orthopedics, Inc., following the purchase of Wright Medical Group’s OrthoRecon Business in January 2014. From December 2006 to January 2014, Mr. Davis served in a number of executive positions for Wright Medical Technology, Inc., a subsidiary of Wright Medical Group, Inc., including President of the OrthoRecon business. From 2004 to 2006, Mr. Davis was a Partner with MB Venture Partners, LLC, a medical technology and life sciences venture capital firm. From 1997 to 2004, Mr. Davis held various positions, ultimately serving as Vice President with Vector Fund Management, a healthcare and life sciences focused venture capital fund. Early in his career, Mr. Davis worked in the healthcare management consulting and pharmaceutical industries. Mr. Davis received a B.E. degree in Biomedical Engineering from Vanderbilt University and an M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University.